GlycoMark, Inc., a company based in Manhattan, New York, is dedicated to improving the management and health of patients with diabetes. GlycoMark, Inc. is the exclusive supplier of the GlycoMark test in the United States, Europe, Australia, Asia-Pacific region and the Middle East. The GlycoMark test is used around the world to enhance the management of glycemic control in patients with diabetes, which has been diagnosed in nearly 10% of the U.S. population and costs the U.S. healthcare system over $325 billion per year.* The company possesses extensive resources to facilitate the discovery and commercialization of innovative biomarkers and new test methodologies for its product portfolio.GlycoMark, Inc. is jointly owned by New York Toyota Tsusho America, Inc. (New York, NY), Toyota Tsusho Corporation (Tokyo, Japan), and Nippon Kayaku Co., Ltd. (Tokyo, Japan).